Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

93 results about "N-Chlorosuccinimide" patented technology

N-Chlorosuccinimide is the organic compound with the formula C₂H₄(CO)₂NCl. A white solid, it is used for chlorinations. It is also used as a mild oxidant. NCS is related to succinimide, but with NCl in place of NH. The N-Cl bond is highly reactive, and NCS functions as a source of "Cl⁺".

A synthetic method for linaclotide

The invention relates to the field of pharmaceutical synthesis, and discloses a synthetic method for linaclotide. The method uses a solid phase one-step cyclization method to prepare linaclotide, andthe linaclotide linear peptide resin is directly cyclized by a N-X-substituted succinimide solution oxidation system without cleavage to obtain linaclotide resin, the resin is cleaved, purified and lyophilized to give linaclotide. The N-X-substitured succinimide is one of N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, and N-hydroxy thiosuccinimide. The method has the following advantages that: 1) solid phase cyclization is adopted, firstly, the pseudo-dilution effect is achieved, repeated folding of the peptide chain is avoided, and the cyclization reaction can be carried out at ahigher concentration, which can greatly improve the production efficiency; secondly, the linear peptide resin is not cleaved before cyclization, avoiding the production of a large amount of impurities and improving the efficiency of linaclotide cyclization; 2) one-step cyclization using N-X-substituted succinimide can avoid multi-step purification of the intermediates, reduce the composition of the intermediate purification step, and improve the total yield of linaclotide; and 3) a specific amino acid side chain protecting group is adopted, thus positioning a pair of disulfide bonds in the cyclization process, reducing the formation of mismatch by-products, improving the purity of linaclotide, greatly improving production efficiency, and reducing the manufacturing cost.
Owner:SHENZHEN JYMED TECH

Preparation method of pharmaceutical intermediate 2-amine methylpyrazine hydrochloride

The invention discloses a preparation method of pharmaceutical intermediate 2-amine methylpyrazine hydrochloride, comprising the following steps: (1) under the protection of nitrogen, 2-methylpyrazine, dibenzoyl peroxide and N-chlorosuccinimide at the molar ratio of 1:0.01-0.1:1-1.3 are added into anhydrous carbon tetrachloride to prepare alpha-chlorine methylpyrazine by reflux reaction; (2) after prepared alpha-chlorine methylpyrazine is mixed with potassium iodide and anhydrous methylbenzene, the mixture is cooled to be below 15 DEG C; then, hexamine is added under stirring, temperature is controlled below 28 DEG C, reaction is carried out when temperature is 0-100 DEG C after adding for 1-20 hours to obtain 2-chlorine methylpyrazine hexamine complex salt; superfluous concentrated hydrochloric acid and solvent alcohol are added into the reaction mixture to react, cool, filter, wash and dry to obtain the coarse product of the 2-amine methylpyrazine hydrochloride; and (3) recrystallization is carried out on the above coarse product in methanol-chloroform to obtain the pharmaceutical intermediate 2-amine methylpyrazine hydrochloride of the invention. The invention has cheap and abundant raw material resource, high overall yield and simple after-treatment and is suitable for industrial production.
Owner:ZAOZHUANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products